Trial Profile
A Non-Interventional, Post-Marketing Surveillance, Phase IV Study to Assess Compliance With Antihypertensive Telmisartan Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2012
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- Acronyms COAST
- Sponsors Bayer
- 02 Mar 2010 Actual patient number (3300 ) added as reported by ClinicalTrials.gov (NCT00470886).
- 02 Mar 2010 Actual patient number (3300 ) added as reported by ClinicalTrials.gov (NCT00470886).
- 02 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov (NCT00470886).